Pancreatic Cancer Research

ResearcherGuangdong Academy of Medical SciencesActive in the last 2 years

Zhou Fang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2024: 1 paper · 2025: 3 papers

Papers 4

  1. Life's Essential 8, genetic susceptibility, and risk of incident pancreatic cancer: A prospective cohort study. Co-author DOI 10.1002/ijc.35184↗
  2. EIF4E-mediated biogenesis of circPHF14 promotes the growth and metastasis of pancreatic ductal adenocarcinoma via Wnt/β-catenin pathway. Co-author DOI 10.1186/s12943-025-02262-5↗
  3. LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways. First author DOI 10.1186/s12951-025-03550-4↗
  4. Endosomal Trafficking Bypassed by the RAB5B-CD109 Interplay Promotes Axonogenesis in KRAS-Mutant Pancreatic Cancer. Co-author DOI 10.1002/advs.202405092↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liangtang Zeng · 2 shared papers, 2025 · strength 0.61
  2. Zhuo Wu · 2 shared papers, 2025 · strength 0.59
  3. Rufu Chen · 2 shared papers, 2024–2025 · strength 0.49
  4. Zhuo Kui Wu · 2 shared papers, 2024–2025 · strength 0.49
  5. Chao Yu · 2 shared papers, 2024–2025 · strength 0.49
  6. Rufu Chen · 1 shared paper, 2025 · strength 0.30
  7. Jinlong Yu · 1 shared paper, 2025 · strength 0.28
  8. Chao Yu · 1 shared paper, 2025 · strength 0.28
  9. Rufu Chen · 1 shared paper, 2025 · strength 0.28
  10. Changhao Chen · 1 shared paper, 2024 · strength 0.19
  11. Min Yu · 1 shared paper, 2024 · strength 0.19
  12. Yuming Luo · 1 shared paper, 2024 · strength 0.19
  13. Jiabin Yang · 1 shared paper, 2024 · strength 0.19
  14. Dingwen Zhang · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.